Several major antiepileptic drugs are substrates for human P-glycoprotein
Top Cited Papers
- 11 September 2008
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 55 (8), 1364-1375
- https://doi.org/10.1016/j.neuropharm.2008.08.032
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System PharmacotherapyPharmacological Reviews, 2008
- Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein Substrate R‐[11C]verapamilEpilepsia, 2007
- Development of a Humanized In Vitro Blood–Brain Barrier Model to Screen for Brain Penetration of Antiepileptic DrugsEpilepsia, 2007
- Means, Motive, and Opportunity: Establishing Culpability in Pharmacoresistant EpilepsyEpilepsy Currents, 2007
- The antiepileptic and anticancer agent, valproic acid, induces P‐glycoprotein in human tumour cell lines and in rat liverBritish Journal of Pharmacology, 2006
- Induction of P‐glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elementsBritish Journal of Clinical Pharmacology, 2006
- Molecular and cellular mechanisms of pharmacoresistance in epilepsyBrain, 2005
- All‐trans retinoic acid enhances differentiation and influences permeability of intestinal Caco‐2 cells under serum‐free conditionsDevelopment, Growth & Differentiation, 2004
- P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brainNeuroReport, 2001
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995